AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2010
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
: The impact of educational group therapy in addition to standard psychiatric care in incarcerated females on treatment outcomes and psychotropic utilization
|
Biglow, Michael | Work in Progress | Session 1 |
|
A Case Study: The Comparative Effects of Clozapine, Olanzapine, Valproic Acid, and Lithium on the WBC and ANC in an Intellectually Disabled Individual.
|
White, Tiffany | Therapeutic Case Report | Session 1 |
|
A clinical pharmacology study to determine the selective and non-selective doses of rasagiline, a monoamine oxidase type B inhibitor
|
Chen, Jack | Encore Presentation | Session 1 |
|
A LONG TERM CARE FACILITY RESIDENT TREATED FOR DEPRESSION WITH PSYCHOTIC FEATURES: MISINTERPRETATION OF FEDERAL TAG F428 BY A STATE PHARMACY SURVEYOR
|
Benefield, William | Therapeutic Case Report | Session 1 |
|
A pilot study on the Side Effect Burden of ADD/ADHD Treatment. Child VS Parent Perspective
|
Clemetson, Rama Krishna | Work in Progress | Session 1 |
|
A Retrospective Evaluation of the Relationship Between Mental Disorders and Patient Adherence to Antiretroviral Therapy
|
Fowler, Jill | Original Research | Session 1 |
|
A stepwise approach to changing the landscape of pharmacist education on pain and palliative care: A report from the Strategic Planning Summit for the Advancement of Pain and Palliative Care Pharmacy.
|
Gable, Kelly | Encore Presentation | Session 2 |
|
Acute dystonia associated with paliperidone in a multi-drug overdose
|
Cunningham, Julie | Therapeutic Case Report | Session 1 |
|
ACUTE EXACERBATION OF FOUR MAJOR MENTAL DISEASE STATES AS DEFINED BY THE FOURTH VERSION OF THE DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS AND THEIR RELATIONSHIP TO MEDICATION ADHERENCE
|
Chou, Tony | Work in Progress | Session 1 |
|
ADJUNCTIVE ARIPIPRAZOLE TREATS SYMPTOMS OF CORE DEPRESSION, ANXIETY, AND INSOMNIA IN PATIENTS WITH ANXIOUS OR NON-ANXIOUS MDD (CN138-139, CN138-163, & CN138-165)
|
Clark, Bill | Encore Presentation | Session 1 |
|
Adverse Drug Reaction Review: Evaluation of Concomitant Medications Effecting Blood Dyscrasias Associated With Clozapine
|
Cole, Miranda | Work in Progress | Session 2 |
|
An Analysis of Cardiovascular Risk within a Mental Health Population
|
Lloyd, Michael | Encore Presentation | Session 1 |
|
An Evaluation of the Effectiveness and Safety of Varenicline in a Veteran Population
|
Givone, Donna | Work in Progress | Session 1 |
|
Anticholinergic use in children and adolescents after initiation of antipsychotic therapy
|
Bishop, Jeffrey | Original Research | Session 2 |
|
Antidepressant Decision Making Aids: Initial Medication Selection in Primary Care and Psychiatric Clinics
|
DeJongh, Beth | Work in Progress | Session 1 |
|
Antidepressant Use in Depressed Kentucky Medicaid Youths
|
Chandler, Hannah | Original Research | Session 1 |
|
Appropriateness of medication use in geriatric patients admitted to an acute inpatient psychiatric service
|
Leloux, Megan | Work in Progress | Session 1 |
|
ARIPIPRAZOLE-INDUCED HICCUPS
|
Kattura, Rania | Therapeutic Case Report | Session 2 |
|
Asenapine as Adjunctive Treatment for Bipolar Mania: A Placebo-Controlled 12-Week Study and 40-Week Extension
|
Panagides, John | Encore Presentation | Session 2 |
|
Assessing remission in major depressive disorder (MDD) and generalized anxiety disorder (GAD) clinical trials with the Discan-metric of the Sheehan Disability Scale (SDS)
|
Thompson, Harry | Encore Presentation | Session 2 |
|
Assessing the Need for Patient Education in Liver Transplant Patients Using Psychiatric Medications
|
Wackernah, Robin | Work in Progress | Session 1 |
|
Assessing the Pharmacokinetics of Venlafaxine ER 75 mg and Desvenlafaxine 50 mg in CYP2D6 Extensive and Poor Metabolizers
|
Kane, Cecelia | Encore Presentation | Session 2 |
|
BEERS CRITERIA MEDICATION REVIEW AND USE WITHIN A STATE PSYCHIATRIC FACILITY
|
Jepsen, Jennifer | Innovative Practices | Session 1 |
|
BODY WEIGHT CHANGES ASSOCIATED WITH MILNACIPRAN MONOTHERAPY IN 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED FIBROMYALGIA TRIALS
|
Escher, Tobie | Encore Presentation | Session 2 |
|
BRIDGING THE TRANSITION FROM HOSPITAL TO HOME: IMPLEMENTATION OF A MEDICATION DISCHARGE PROGRAM
|
Montgomery, Jamie | Innovative Practices | Session 2 |
|
Can pharmacists improve early detection and management of metabolic syndrome due to second generation antipsychotic agents?
|
Schneiderhan, meschnei@d.umn.edu | Work in Progress | Session 1 |
|
CHANGES IN PARENTAL STRESS WITH GUANFACINE EXTENDED RELEASE IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND OPPOSITIONAL SYMPTOMS
|
Youcha, Sharon | Original Research | Session 1 |
|
Characterization of Medication Discrepancies Occurring at the Time of Discharge from a State Psychiatric Inpatient Faciility
|
Nelson, Leigh Anne | Original Research | Session 1 |
|
Clinical characteristics of heavy and light smokers with schizophrenia
|
Wehring, Heidi | Encore Presentation | Session 1 |
|
Clozapine-Rechallenge Resulting in Agranulocytosis: Treatment with Granulocyte Colony-Stimulating Factor (G-CSF)
|
Harris, Suzanne | Therapeutic Case Report | Session 2 |
|
COLLABORATION BETWEEN A DOCTOR OF PHARMACY CANDIDATE AND A JURIS DOCTOR CANDIDATE IDENTIFYING THE FUNDAMENTAL RIGHTS OF PERSONS WITH SCHIZOPHRENIA AS APPLICABLE TO PSYCHIATRIC ADVANCED DIRECTIVES
|
Stilwell, Emily | Innovative Practices | Session 2 |
|
Collaborative Depression Management in Rural Primary Care
|
Cobb, Carla | Innovative Practices | Session 2 |
|
Collaborative Practice Between a Psychiatric Pharmacist and a Child and Adolescent Psychiatrist in an Private Outpatient Clinic
|
Chavez, Benjamin | Innovative Practices | Session 2 |
|
Contribution of pharmacy students to pain management
|
Columbus, Ericka | Encore Presentation | Session 2 |
|
COST ANALYSIS IN MANAGED CARE PLANS FOR PATIENTS WITH BIPOLAR DEPRESSION WHO INITIATED THERAPY WITH QUETIAPINE XR AND ARIPIPRAZOLE
|
Hassan, Mariam | Original Research | Session 2 |
|
COST IMPACT OF A PHARMACIST-MANAGED LONG-ACTING INJECTABLE ANTIPSYCHOTIC CLINIC
|
Phan, Stephanie | Innovative Practices | Session 2 |
|
DEVELOPMENT OF A PHARMACY TOOL KIT FOR THE STUDY OF ANTIPSYCHOTIC DRUGS USING MEDI-CAL ADMINISTRATIVE AND PHARMACY DATA
|
Chan, Pauline | Innovative Practices | Session 2 |
|
DIFFERENCES IN PSYCHOTROPIC MEDICATION UTILIZATION PATTERNS WITHIN FORENSIC AND NON-FORENSIC PATIENT POPULATIONS
|
Koechle, Brad | Work in Progress | Session 1 |
|
DOES TYPE OF BIPOLAR DISORDER INCREASE THE RISK OF MEDICATION NON-ADHERENCE?
|
Farhadian, Sanaz | Work in Progress | Session 2 |
|
DOSING OF DIVALPROEX SODIUM IN AN ELDERLY POPULATION WITH DEMENTIA; ASSOCIATION WITH SAFETY AND LENGTH OF STAY
|
Leung, Jonathan | Work in Progress | Session 2 |
|
Double Blind, Randomized Control Trial of using Corticosteroids to Treat PTSD
|
Johnson, Catherine | Original Research | Session 1 |
|
Drug interaction between meropenem and divalproex sodium in a patient with schizoaffective disorder
|
Muzyk, Andrew | Therapeutic Case Report | Session 2 |
|
Dual Versus Mono Responders in Fibromyalgia Patients With Major Depressive Disorder
|
Piezer, Kevin | Encore Presentation | Session 2 |
|
Duloxetine In the Prevention of Depressive Recurrence: Outcomes from the Open-Label Acute and Continuation Study Phases
|
Thompson, Harry | Encore Presentation | Session 2 |
|
DULOXETINE-INDUCED SEIZURE BREAKTHROUGH WITH POSITIVE DECHALLENGE AND RECHALLENGE
|
Millares, Catherine | Therapeutic Case Report | Session 1 |
|
Dysphagia associated with Aripiprazole: A Case Report
|
Kuenast, Marcia | Therapeutic Case Report | Session 1 |
|
Early Changes in Selected Attention-deficit/Hyperactivity Disorder Rating Scale Items for Predicting Longer-term Response to Atomoxetine in Pediatric Patients
|
Anerson, Susan | Encore Presentation | Session 2 |
|
Eastern Kentucky Opiate Use for Chronic Non-malignant Pain
|
Moody, Brianna | Innovative Practices | Session 1 |
|
EFFECT OF A QUALITY IMPROVEMENT PROGRAM TO DECREASE ANTIPSYCHOTIC POLYPHARMACY OVER TIME
|
Goren, Jessica | Original Research | Session 1 |
|
EFFECT OF EXCESSIVE MEDICATION DOSING ON HEALTH RESOURCE UTILIZATION OF POSTTRAUMATIC STRESS DISORDER PATIENTS
|
Lacro, Jonathan | Original Research | Session 2 |
|
EFFECT OF MILNACIPRAN IN IMPROVING FATIGUE IN PATIENTS WITH FIBROMYALGIA: RESULTS FROM 3 RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIALS
|
Escher, Tobie | Encore Presentation | Session 2 |
|
Effect of omeprazole on clozapine pharmacokinetics in patients with chronic schizophrenia
|
Risbood, Vineeta | Work in Progress | Session 2 |
|
Effect of the implementation of a pharmacist-operated medication therapy management clinic on psychotropic medication misdadventures among active duty soldiers with traumatic brain injury
|
Farinde, Abimbola | Work in Progress | Session 2 |
|
EFFECTS OF GUANFACINE EXTENDED RELEASE ON INDIVIDUAL OPPOSITIONAL SYMPTOMS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND THE PRESENCE OF OPPOSITIONAL SYMPTOMS
|
Youcha, Sharon | Original Research | Session 1 |
|
EFFECTS OF THE CANNABINOID-1 RECEPTOR ANTAGONIST RIMONABANT ON PSYCHIATRIC SYMPTOMS IN OVERWEIGHT PEOPLE WITH SCHIZOPHRENIA: A RANDAMIZED, DOUBLE-BLIND PiLOT STUDY
|
Kelly, Deanna | Encore Presentation | Session 2 |
|
EFFICACY AND SAFETY OF LISDEXAMFETAMINE DIMESYLATE IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN THE ADULT WORKPLACE ENVIRONMENT
|
DeLeon, Anthony | Encore Presentation | Session 1 |
|
EFFICACY OF ADJUNCTIVE ARIPIPRAZOLE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH MINIMAL OR PARTIAL RESPONSE TO ANTIDEPRESSANT THERAPY (CN138-139, 163 & 165)
|
McGuire, Michael | Encore Presentation | Session 2 |
|
EFFICACY OF GUANFACINE EXTENDED RELEASE IN CHILDREN WITH OPPOSITIONAL SYMPTOMS AND ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A RESPONDER ANALYSIS
|
Lopez, Frank | Original Research | Session 1 |
|
Evaluating the effects of individual counseling in psychiatric patients identified with highly complex regimens or high-risk medications at the time of discharge
|
Tangu, Keumboh | Encore Presentation | Session 2 |
|
Evaluating the efficacy and adherence to a symptom triggered alcohol withdrawal protocol
|
Lizer, Mitsi | Original Research | Session 1 |
|
Evaluating the frequency of as-needed dosing for anxiety/agitation in smoking versus non-smoking patients with schizophrenia
|
Shankar, Gollapudi | Encore Presentation | Session 2 |
|
EVALUATION OF METABOLIC PARAMETERS IN AN EARLY PSYCHOSIS PATIENT POPULATION
|
Wells, Daina | Work in Progress | Session 1 |
|
Evaluation of Paliperidone in Improving Positive Symptoms vs. Negative Symptoms in an Inpatient Psychiatric Facility
|
Montes, Amy | Encore Presentation | Session 2 |
|
Evaluation of pharmacotherapeutic regimens in patients with a history of traumatic brain injury and co-morbid post-traumatic stress disorder
|
Morgan, Meghan | Work in Progress | Session 2 |
|
Evaluation of the effects of individual discharge counseling of patients versus group counseling and recidivism rate in a state psychiatric hospital
|
Abobo, Vivian | Encore Presentation | Session 2 |
|
EVALUATION OF TREATMENT CONTINUATION RATES OF ARIPIPRAZOLE AND QUETIAPINE IN PATIENTS WITH BIPOLAR DISORDER
|
Kreys, Tiffany-Jade | Original Research | Session 1 |
|
Frequency of Follow-up Monitoring after Antidepressant Initiation in the Primary Care Setting of a Veteran Affairs Medical Center
|
Slear, Kelly | Work in Progress | Session 1 |
|
Group versus Individual Counseling: A Comparative Analysis of Patients in a State Psychiatric Hospital
|
Tangu, Keumboh | Encore Presentation | Session 2 |
|
Heart Failure Exacerbation Caused by Serotonin-Norepinephrine Reuptake Inhibitors
|
Givone, Donna | Work in Progress | Session 1 |
|
Impact of a symptom-triggered alcohol withdrawal protocol on benzodiazepine use and length of stay in an adult dual diagnosis population
|
Maroney, Megan | Work in Progress | Session 1 |
|
Impact of Ethnicity on Efficacy and Safety During Treatment with Olanzapine in Schizophrenia
|
Piezer, Kevin | Original Research | Session 2 |
|
Impact on monitoring of fasting lipid panel and fasting plasma glucose in patients prescribed second generation antipsychotics with the implementation of an ambulatory pharmaceutical care service.
|
Klein, Matthew | Work in Progress | Session 2 |
|
Implementation and Outcomes of a Pharmacy Managed Clinic for Veterans in a Substance Abuse Residential Rehabilitation Treatment Program
|
McNeil, Julie | Work in Progress | Session 1 |
|
IMPLEMENTATION OF THE ILLNESS MANAGEMENT AND RECOVERY (IMR) TREATMENT MODEL ON AN INPATIENT ADULT PSYCHOTIC UNIT: USE OF PRO RE NATA (PRN) MEDICATIONS AND ADDITIONS TO MEDICATION REGIMEN
|
Eon, Stacy | Work in Progress | Session 1 |
|
Improving Patient Medication Adherence after Pharmacist Counseling upon Discharge from a Mental Health Facility
|
Huang, Melody H | Innovative Practices | Session 1 |
|
Inconsistency in Risperidone Long-Acting Injection Steady-State Plasma Levels When Switching From Deltoid to Gluteal Administration
|
Nelson, Leigh Anne | Therapeutic Case Report | Session 1 |
|
INHALED LOXAPINE (AZ-004) RAPIDLY AND EFFECTIVELY REDUCES AGITATION IN PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER
|
Cassella, James | Original Research | Session 2 |
|
Is 300 mg of quetiapine XR an appropriate starting dose in antipsychotic-naive patients?
|
Khoury, Abir | Therapeutic Case Report | Session 2 |
|
Knowledge, attitudes, beliefs and practice of pharmacists regarding counseling of chemical dependent patients
|
Tomko, tomko170@duq.edu | Original Research | Session 1 |
|
LABORATORY ASSAYS IN A PSYCHIATRIC INPATIENT SETTING: DETERMINING VALUE OR WASTE.
|
Poulsen, Dallin | Original Research | Session 1 |
|
LASTING EFFECTS OF FLUPHENAZINE DECANOATE: A CASE REPORT
|
Hieber, Robin | Therapeutic Case Report | Session 1 |
|
Leuprolide-induced mania with psychotic symptoms in a male patient with no prior psychiatric history
|
Chavez, Benjamin | Therapeutic Case Report | Session 1 |
|
Long-Term Asenapine Treatment for Bipolar Disorder: A Double-Blind 40-Week Extension Study
|
McIntyre, Roger S. | Encore Presentation | Session 1 |
|
Long-Term Safety and Efficacy of Asenapine Versus Olanzapine in Patients With Schizophrenia or Schizoaffective Disorder
|
Schoemaker, Joep | Encore Presentation | Session 2 |
|
LONG-TERM SAFETY AND TOLERABILITY OF OPEN-LABEL ARIPIPRAZOLE AUGMENTATION OF ANTIDEPRESSANT THERAPY IN MAJOR DEPRESSIVE DISORDER (STUDY CN138-164)
|
Carlton, Tarolyn | Encore Presentation | Session 1 |
|
Long-Term Smoking Cessation Outcomes in a Veteran Population
|
Hawley, Joanne | Work in Progress | Session 2 |
|
MEDICATION ADHERENCE AND HEALTH RESOURCE UTILIZATION IN VETERANS AFFAIRS PATIENTS WITH POST TRAUMATIC STRESS DISORDER (PTSD)
|
Allwine, Rachael | Work in Progress | Session 1 |
|
Medication Adherence and Healthcare Outcomes in PTSD Patients Prescribed 5 or more Psychotropic Medications
|
Rathbun, Robert | Original Research | Session 2 |
|
Medication Use Evaluation: Metabolic Side Effects of Paliperidone in an Inpatient Psychiatric Facility
|
Everitt, Amy | Encore Presentation | Session 1 |
|
METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) 677C/T AND CATECHOL-O-METHYLTRANSFERASE (COMT) VAL158MET VARIANTS AND ENDOTHELIAL FUNCTIONING IN SCHIZOPHRENIA SUBJECTS TREATED WITH ANTIPSYCHOTICS
|
Ellingrod, Vicki | Work in Progress | Session 2 |
|
MILNACIPRAN 100 MG/DAY IN THE TREATMENT OF FIBROMYALGIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
|
Escher, Tobie | Encore Presentation | Session 2 |
|
MILNACIPRAN IMPROVES PHYSICAL FUNCTION IN PATIENTS WITH FIBROMYALGIA: POOLED RESULTS FROM 3 PHASE III TRIALS
|
Escher, Tobie | Encore Presentation | Session 2 |
|
Mirtazapine Induced Pancytopenia
|
Acholonu, Wilfred | Therapeutic Case Report | Session 1 |
NOOTROPIC-INDUCED PSYCHOSIS: A CASE REPORT
|
Breden, Ericka | Therapeutic Case Report | Session 1 |
|
Olanzapine-Induced Asymptomatic Pancreatitis: A Case Report
|
Whittington, Karen | Therapeutic Case Report | Session 1 |
|
ONLINE PSYCHIATRIC PHARMACY ELECTIVE COURSE ON SCHIZOPHRENIA: STUDENT FEEDBACK
|
Price, Scott | Innovative Practices | Session 2 |
|
Open-label naturalistic study of pregabalin for cervical dystonia and other hyperkinetic movement disorders (HMDs): Effectiveness and tolerability.
|
Chen, Jack | Encore Presentation | Session 1 |
|
Oseltamivir Use In Psychiatric Inpatients Taking Clozapine: Effect On Psychiatric Symptomatology
|
Allen, Shari | Work in Progress | Session 1 |
|
OUTPATIENT COMPLIANCE RATES WITH LONG-ACTING INJECTABLE ANTIPSYCHOTIC THERAPY
|
Kreys, Tiffany-Jade | Work in Progress | Session 2 |
|
Pediatricians' Self-Reported Treatment and Pharmacotherapy Monitoring of Children and Adolescents with Major Depressive Disorder
|
Schwab, Maura | Work in Progress | Session 1 |
|
Pharmacist Administration of Long-Acting Antipsychotic Injections in a Community Setting
|
Singer, Brandy | Innovative Practices | Session 1 |
|
PHARMACIST-DIRECTED PTSD MEDICATION MANAGEMENT CLINIC AT THE VAWNY HEALTHCARE SYSTEM
|
Hyatt, Judy | Innovative Practices | Session 1 |
|
PHARMACIST-DRIVEN MANAGEMENT OF PAIN AND FALLS ASSOCIATED WITH POSTHERPETIC NEURALGIA AMONG RESIDENTS OF NURSING HOME FACILITIES: ASSESSMENT OF INTERVENTIONS AND RELATIVE CLINICAL OUTCOMES BY THE CONSULTANT PHARMACIST
|
Davis, Alan | Work in Progress | Session 1 |
|
Pharmacist-Enhanced Medication Reconciliation Services at an Outpatient Addiction Medicine Clinic
|
Chan, Terri | Innovative Practices | Session 2 |
|
Pharmacy Student Perspectives on Mental Illness and the Impact of a Mental Health Elective
|
Muhlstadt, Katherine | Work in Progress | Session 1 |
|
Pilot study of Cue Induced Targeting of Transcranial Magnetic Stimulation (TMS) in Nicotine Addiction
|
Boggs, Douglas | Work in Progress | Session 1 |
|
Potential acute dystonic reaction in a fifteen year old on quetiapine fumarate extended release tablets
|
Price, Paul | Encore Presentation | Session 1 |
|
Potential modafinil abuse in a 46 year old male
|
Price, Paul | Therapeutic Case Report | Session 1 |
|
Potential risperidone induced acute dystonic reaction in a five year old
|
Price, Paul | Encore Presentation | Session 1 |
|
PRACTITIONERS' USE AND PERCEPTIONS OF PERSONALITY DISORDER KNOWLEDGE IN PRACTICE AND TEACHING
|
Fuentes, David | Work in Progress | Session 1 |
|
Predictors of relapse in a study of duloxetine treatment in patients with generalized anxiety disorder
|
Anderson, Susan | Encore Presentation | Session 2 |
|
PRESCRIBING PREVALENCE AND TRENDS OF LOW-DOSE QUETIAPINE IN A LARGE ACADEMIC MEDICAL CENTER
|
Moeller, Karen | Encore Presentation | Session 2 |
|
Prevalence of alcohol abuse and consumption among pharmacy students at four US schools of pharmacy
|
English, Clayton | Original Research | Session 2 |
|
Pronounced and sustained tachycardia associated with the use of atypical antipsychotics during inpatient hospitalization.
|
Melillo, Stephanie | Original Research | Session 1 |
|
Psychiatric Pharmacy Practice in the Corrections Setting
|
McKee, Jerry | Innovative Practices | Session 2 |
|
Psychiatric Pharmacy Practice within the Army Medical Department
|
Dandridge, Debra | Innovative Practices | Session 2 |
|
Qualitative Analysis and Cost Avoidance of Clinical Pharmacy Interventions Made by Doctor of Pharmacy Students at a Psychiatric Hospital
|
Campbell, Austin | Work in Progress | Session 2 |
|
Quality of Monitoring for Metabolic Effects Associated with Second Generation Antipsychotics: Effects of Practice Guideline Dissemination in Persons with Schizophrenia on Public Insurance
|
Moeller, Karen | Original Research | Session 1 |
|
RATES OF ADHERENCE FOR THE FILLING OF ANTIDEPRESSANT PRESCRIPTIONS IN A MEDICAID POPULATION WITH CHRONIC PAIN AND DEPRESSION
|
Morrison, Sarah | Work in Progress | Session 2 |
|
Relation of Symptom Experience with Anticholinergic Drug Exposure in Older Veterans
|
Carnahan, Ryan | Original Research | Session 2 |
|
REVISED FEDERAL PRESCRIBING RULES GOVERNING PSYCHOTROPIC MEDICATION VERSUS PUBLISHED TREATMENT GUIDELINES OF SELECTED AXIS I DISORDERS: PRACTICE STRATEGIES IN LONG TERM CARE PSYCHIATRIC PHARMACY
|
Shi, Leanna | Innovative Practices | Session 1 |
|
Risperidone-induced urinary incontinence and reoccurrence with paliperidone
|
Liu, Mei | Therapeutic Case Report | Session 1 |
|
Role of a Psychiatric Pharmacist In a Los Angeles "Skid Row" Safety-net Clinic
|
Wang, Indriani | Innovative Practices | Session 1 |
|
SCHIZOPHRENIA AND THE IMMUNE SYSTEM: ADAPTIVE IMMUNITY
|
Richard, Michelle | Innovative Practices | Session 2 |
|
Stability of clozapine in oral suspension: a comparison of high performance liquid chromatography (HPLC) and mass spectrometry assays from day zero through day sixty
|
Lee, Jennifer | Work in Progress | Session 2 |
|
Strategies to Accelerate Drug Development for CNS Compounds: Focus on Schizophrenia
|
Ereshefsky, Larry | Encore Presentation | Session 2 |
|
STUDENT PERCEPTIONS ON THE USE OF BLACKBOARD TO DELIVER COURSE MATERIALS IN A PSYCHIATRIC PHARMACY ELECTIVE
|
Brahm, Nancy | Original Research | Session 2 |
|
TAILORING THE REVISED FEDERAL PRESCRIBING RULES IN RESIDENTS RECEIVING ANTIDEPRESSANT PHARMACOTHERAPY: A FOUR-YEAR EXPERIENCE IN LONG TERM CARE FACILITIES
|
Cooper, Champion | Innovative Practices | Session 1 |
|
The catechol-o-methyltransferase (COMT) Val158Met polymorphism and antisaccade response to antipsychotics in first episode psychosis
|
Bishop, Jeffrey | Encore Presentation | Session 2 |
|
The Effect of Caffeine on the Pupillary Light Reflex.
|
Wright, Alan | Work in Progress | Session 1 |
|
The Effect of Psychotropic Medication Dosing on Symptom Control for Inmates with Bipolar Disorder
|
Megan Ehret, meganehret@hotmail.com | Original Research | Session 1 |
|
The Effects of Second-Generation Antipsychotics on Executive Function: A Literature Review and Meta-analysis
|
Pope, Parris | Original Research | Session 1 |
|
The Evaluation of the Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting
|
Furmaga, Kevin | Work in Progress | Session 1 |
|
The First CPNP Collegiate Chapter in the United States: The Development Process
|
Everitt, Amy | Innovative Practices | Session 1 |
|
The Heterogeneity of Antipsychotic Response in the Treatment of Schizophrenia
|
Brackins, Todd | Original Research | Session 1 |
|
The Prediction of Addiction Risk in Student Pharmacists
|
Klugh Kennedy Pharm.D, BCPP, Merrill Norton Pharm.D.,D.Ph.,CCDP-D | Work in Progress | Session 2 |
|
Use of aripiprazole in a multiple sclerosis patient presenting with paranoid psychosis
|
Muzyk, Andrew | Therapeutic Case Report | Session 2 |
|
USE OF COGNITIVE AND PERFORMANCE ENHANCING MEDICATIONS (CPEMs) IN AN INTERNATIONAL SAMPLE OF SELF-IDENTIFIED POKER PLAYERS
|
Caballero, Joshua | Original Research | Session 1 |
|
USE OF HIGH-DOSE ATYPICAL ANTIPSYCHOTICS FOR TREATMENT OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER IN A VETERAN POPULATION
|
Smith, Ashley | Work in Progress | Session 1 |
|
Varenicline and Mental Health Stability in Patients with Post-Traumatic Stress Disorder: A Retrospective Cohort Study of 78 Patients at a Single Veterans Affairs Medical Center
|
Campbell, Austin | Original Research | Session 2 |
|
Venlafaxine Efficacy Varies With CYP2D6 Phenotype in Patients Treated for Depression
|
Lobello, Kasia | Encore Presentation | Session 2 |
|
Zolpidem Use in Resolution of Catatonia Complicated by Neuroleptic Malignant Syndrome (NMS): A Case Report
|
Cruz, Martin | Therapeutic Case Report | Session 2 |